YOU ARE HERE: LAT HomeCollectionsAttention Deficit Disorder

Attention Deficit Disorder

January 8, 2001 | From Associated Press
Children with attention deficit/hyperactivity disorder receive more medical care than other youngsters for non-behavioral problems such as injuries, infections and asthma, Mayo Clinic researchers say. However, it is unclear from the findings whether such youngsters really have more such medical problems or are simply diagnosed more often because they get closer attention from doctors. The study looked at more than 4,000 children living near the Rochester, Minn., clinic.
February 21, 1995 | JULIE MARQUIS
UC Irvine researchers are seeking children with Attention Deficit Hyperactivity Disorder to participate in what is expected to be a landmark study of treatments, including psychosocial methods and medication. Participants must be between 7 and 9 years old and must be considered to have the disorder by parents, school officials or other health and educational professionals.
June 23, 2011 | By Philip Hersh
At 29, Justin Gatlin is a seasoned sprinter who felt like a rookie while winning his first-round heat of the 100 meters Thursday at the U.S. Championships. Gatlin had won the Olympic 100 in 2004, the world championship 100 and 200 in 2005 and what looked like his second consecutive U.S. 100 title in 2006, when he was a superstar in the sport. He had not run in a national championship since then. "I don't feel old," Gatlin said. "I just feel a little rusty. I have a veteran mentality, but I'm actually maybe a rookie.
March 23, 2006 | Ricardo Alonso-Zaldivar, Times Staff Writer
A Food and Drug Administration advisory panel on Wednesday urged beefed-up warnings for drugs used to treat attention deficit disorder after hearing about hundreds of cases in which children using the medications experienced frightening hallucinations, often involving bugs and snakes.
February 22, 2007 | Jonathan D. Rockoff, The Baltimore Sun
The makers of Ritalin, Adderall, Strattera and other drugs treating attention-deficit hyperactivity disorder were advised by the government Wednesday to give patients and their parents an additional warning that those medicines could cause serious psychiatric and heart problems, including sudden death.
April 20, 2008 | Bill Shaikin
You've seen the play a million times. Routine ground ball. First baseman picks up the ball, runs it to the bag for the out, "3U" in your scorebook. Adam LaRoche picked up the ball, but he did not run. "I was kind of out of it," he said. He walked the ball to the bag. The runner beat him there. "I wasn't even thinking there was a runner," LaRoche said. The crowd booed, his home crowd. LaRoche apologized to his pitcher, then his manager. "It looked like I was being lazy," he said.
December 9, 2001 | Sandy Banks
She's difficult to miss on the soccer field. She's the one berating a teammate for missing a kick, complaining when a ref's call doesn't go her way, shouting down her coach as he yells advice. On the sidelines, the parents watching her antics shake their heads and roll their eyes. "She's so disagreeable," one father whispers. "It's hard to believe she's having fun out there." I see her mother bite her lip and grip the arms of her folding chair, as she watches her daughter dribble past a defender, then boot the ball into the goal to score.
Susan Callison will never forget how terrified she was when at the beginning of second grade, it took her son, Chad, two hours to complete a simple homework spelling assignment. "I remember working with him on the word boat. I used pictures, everything, to try to help him recognize the word," said the El Toro mother and former teacher. "But after 20 minutes of working, he still didn't have a clue. It was frightening."
March 7, 2006 | Terry McDermott, Times Staff Writer
Irvine-based Cortex Pharmaceuticals Inc. announced positive results Monday from initial clinical trials for a drug to treat attention deficit hyperactivity disorder. The test, conducted on 65 people across the U.S., showed that the drug significantly reduced key ADHD symptoms, said Lenard Adler of the New York University School of Medicine, who ran one of the trials. Cortex immediately announced it would take the drug, one of a family of drugs called ampakines, into larger trials.
Los Angeles Times Articles